The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia.

Journal: Cancer control : journal of the Moffitt Cancer Center •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Wang YL, Lee WJ, Chang TY, et al. (2026). "The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia.". Cancer control : journal of the Moffitt Cancer Center. https://doi.org/10.1177/10732748261495568